Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Stachowicz A
Application of nano composites in the fixation and processing of histological material
(R)-roscovitine
0%) in the treatment of seborrhoeic dermatitis
AEE788 (50 mg/kg) also inhibits growth of tumors in the cecum and peritoneum (>50%) and reduces the incidence of lymph node metastasis to 70% in HT29 cells implanted in the cecum of nude mice
SQ109 Size:Solid 2 mg Stachowicz ASQ109 is a drug undergoing development for treatment of tuberculosis. SQ109 showed activity against both drug susceptible and Multi drug resistant tuberculosis bacteria, including Extensively drug resistant tuberculosis strains. In preclinical studies SQ109 enhanced the activity of anti tubercular drugs isoniazid and rifampin and reduced by >30% the time required to cure mice of experimental TB. SQ109 is being developed by OOO Infectex in Russia and
US$ 28.00
US$ 425.00
US$ 1010.00
US$ 665.00
US$ 1032.50
US$ 1000.00
US$ 3450.00
US$ 892.50
US$ 1400.00
US$ 499.50